Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Does Pharmacodynamics of Drugs Change After Presenting Them As Na-Noparticles Like Their Pharmacokinetics? Publisher Pubmed



Jafari RM1 ; Ala M1, 2 ; Goodarzi N3 ; Dehpour AR1, 2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Phar-macology, School of Medicine, Tehran University of Medical Sciences, Tehran, 13145-784, Iran
  3. 3. Nanotechnology Research Centre, Tehran University of Medical Sciences, Tehran, Iran

Source: Current Drug Targets Published:2020


Abstract

Nowadays, the breakthrough in different medical branches makes it feasible to designate new methods of drug delivery to achieve the most cost-effective and the least unpleasant consequence-imposing solutions to overcome a wide range of diseases. Nanoparticle (NP) drugs entered the therapeutic system, especially in cancer chemotherapy. These drugs are quite well-known for two traits of being long-acting and less toxic. For a long time, it has been investigated how NPs will change the kinetics of drugs. However, there are a few studies that in-clined their attention to how NPs affect the dynamics of drugs. In this review, the latter point will mainly be discussed in an example-based manner. Besides, other particular features of NPs will be briefly noted. NPs are capable of affecting the biologic system as much as a drug. Moreover, NPs could arise a wide variety of effects by triggering their own receptors. NPs are able to change a receptor function and manipulate its downstream signaling cascade. © 2020 Bentham Science Publishers.
Other Related Docs
13. Biomedical Applications of Intelligent Nanomaterials, Intelligent Nanomaterials: Second Edition (2016)
15. Gold Nanoparticles for Biomedical Imaging and Their Biological Response, New Developments in Gold Nanomaterials Research (2016)
16. Folate-Conjugated Gold Nanoparticle As a New Nanoplatform for Targeted Cancer Therapy, Journal of Cancer Research and Clinical Oncology (2016)
17. Nanocarriers Usage for Drug Delivery in Cancer Therapy, International Journal of Cancer Management (2016)
20. Protein Corona: Opportunities and Challenges, International Journal of Biochemistry and Cell Biology (2016)
21. Lipid-Based Nanoparticles for Drug Delivery Systems, Characterization and Biology of Nanomaterials for Drug Delivery: Nanoscience and Nanotechnology in Drug Delivery (2018)
28. Solid Silica Nanoparticles: Applications in Molecular Imaging, Contrast Media and Molecular Imaging (2015)
33. Ph-Sensitive Stimulus-Responsive Nanocarriers for Targeted Delivery of Therapeutic Agents, Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology (2016)
34. Disease Specific Protein Corona, Progress in Biomedical Optics and Imaging - Proceedings of SPIE (2015)
35. Unravelling Toxoplasma Treatment: Conventional Drugs Toward Nanomedicine, World Journal of Microbiology and Biotechnology (2021)
36. Critical Parameters to Translate Gold Nanoparticles As Radiosensitizing Agents Into the Clinic, Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology (2023)
47. Protein Corona: Challenges and Opportunities for Cancer Therapy, Functionalized Nanomaterials for Cancer Research: Applications in Treatments# Tools and Devices (2024)